Modern Healthcare Meets Purpose-Driven Innovation
Entrepreneur, investor and Dragon’s Den star Michele Romanow has teamed up with Science&Humans, a forward-thinking hormone health platform transforming access to personalised clinical care across Canada.
The partnership brings Romanow’s business leadership and audience reach to Science&Humans’ mission of delivering evidence-based hormone health services in an accessible, technology-enabled format. Through collaborative content and strategic engagement, Romanow will help amplify awareness around hormone wellness solutions, from reproductive health to metabolic balance and menopause support.
“We are thrilled to announce our investment in Science&Humans, a company building an integrated platform for hormone health through at-home diagnostics, virtual clinical consults and vertically integrated pharmacy experience. The investment comes as part of a Series A financing that we led with participation from WELL health, Michele Romanow and a group of US-based family offices and clinicians.” – Pender Ventures
About Michele Romanow
Michele Romanow is a Canadian entrepreneur and venture investor best known for her role as a featured investor on Dragon’s Den. With a strong track record of backing data-driven, technology-led businesses, she has built a reputation for supporting companies that solve real-world problems at scale. Her interest in healthcare innovation and scalable digital platforms makes her a natural fit for Science&Humans, whose integrated approach to hormone health aligns closely with her focus on evidence-based solutions and accessible care. Through the partnership, Romanow brings both strategic insight and advocacy to a campaign centred on modernising hormone health and expanding access to trusted clinical support.
About Science&Humans
Science&Humans is a vertically integrated hormone health platform dedicated to modernising how people understand and manage hormone-related conditions. Using at-home diagnostics, virtual clinical consultations and seamless pharmacy integration, the platform supports individuals navigating issues such as hormone imbalance, fertility concerns, perimenopause and menopause, metabolic health and testosterone optimisation. The company also partners with employers and insurers to extend hormone care access at scale.
“Science&Humans has built a differentiated, evidence-based platform for hormone care—an area that has been historically underdiagnosed and underserved,” said Meryeme Lahmami, principal at Pender Ventures.
Advancing Hormone Health Together
Romanow’s involvement will support Science&Humans as it continues expanding its service offerings and reaching new audiences with trusted, clinically grounded care. Together, the partnership aims to destigmatise conversations about hormone health while showcasing solutions that empower users to take control of their wellbeing.
With Michele Romanow’s strategic support, Science&Humans is positioned to accelerate its vision for inclusive, science-backed hormone care, helping individuals live healthier, more balanced lives.